Table 1 Main clinical and laboratory parameters of objections
Parameters | SLE | Healthy control |
|---|---|---|
n | 44 | 45 |
Age | 30.5 ± 1.6 | 31.8 ± 1.5 |
SLEDAI | 9.3 ± 3.8 | NA |
Disease duration (month) | 17.9 + 1.9 | NA |
Skin involvement, P/N (n) | 30/15 | NA |
Alopecia, P/N (n) | 12/33 | NA |
Arthritis, P/N (n) | 24/21 | NA |
Lupus nephritis, P/N (n) | 20/25 | NA |
Leukopenia, P/N (n) | 7/38 | NA |
Anti-ANA, P/N (n) | 43/2 | NA |
Anti-dsDNA, P/N (n) | 20/25 | NA |
Anti-Sm, P/N (n) | 12/33 | NA |
C3 or C4 deficiency, P/N (n) | 31/14 | NA |
Medication | ||
None | 3 | NA |
Prednisone ≤ 30 mg/day | 22 | NA |
Prednisone > 30 mg/day | 20 | NA |